Drug Resistance in Non-Small Cell Lung Cancer
Author Information
Author(s): Volm M, Koomägi R, Mattern J, Efferth T
Primary Institution: German Cancer Research Centre, Heidelberg, Germany
Hypothesis
The analysis of protein expression profiles may predict drug resistance in non-small cell lung cancer more accurately than single gene studies.
Conclusion
The study identified three distinct drug resistance profiles in non-small cell lung cancer, with varying expression of resistance-related proteins.
Supporting Evidence
- 70 out of 94 patients had resistant carcinomas, while 24 were sensitive.
- Cluster analysis revealed that the most frequent drug resistance profile was present in 77% of cases.
- Six resistance proteins were significantly related to sensitivity/resistance.
Takeaway
Researchers looked at how different proteins in lung cancer cells can show if the cancer will resist treatment. They found three main patterns of resistance.
Methodology
The study evaluated 40 cellular parameters in tumor specimens using immunohistochemistry and hierarchical cluster analysis.
Potential Biases
Potential biases may arise from the selection of patients and the methods used for protein detection.
Limitations
The study's findings may not apply to all patients due to the specific characteristics of the sample population.
Participant Demographics
94 patients (83 men, 11 women) with previously untreated non-small cell lung cancer, mean age 59 years.
Statistical Information
P-Value
p<0.1
Statistical Significance
p<0.1
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website